The East Sussex Healthcare NHS Trust is seeking a supplier to provide Badgernet, a comprehensive electronic patient record system specifically designed for neonatal care. This system will be utilized across the entire neonatal network to accurately record and document essential information for all b
Contract awarded. Originally published 1 years ago.
Eastbourne Healthcare Partnership requires a non-obstetric ultrasound service provider to deliver diagnostic imaging services across multiple clinical specialties.
East Sussex Healthcare NHS Trust is seeking a supplier for the MedCurrent iRefer Clinical Decision Support (CDS) Software. This cloud-hosted Software-as-a-Service solution is designed to assist healthcare professionals in making informed decisions based on the Royal College of Radiologists (RCR) iRe
East Sussex Healthcare NHS Trust is seeking a supplier to provide benchmarking and performance intelligence services through CHKS, which is the Trust's established benchmarking service. This service is essential for driving performance improvements, ensuring the safe delivery of care, and enhancing
East Sussex Healthcare NHS Trust is seeking a supplier to provide managed services for Microsoft SQL Server. This includes monitoring and managing database files and individual database instances to ensure optimal performance and reliability. The contract is valued at £279,132 and the deadline for s
The KKH (Kaufmännische Krankenkasse) is seeking to establish non-exclusive discount agreements with pharmaceutical companies for specific active ingredients under the Open-House procedure. This opportunity is open to all qualified pharmaceutical companies interested in entering into discount agreeme
The Kaufmännische Krankenkasse (KKH) aims to establish discount agreements with all suitable pharmaceutical companies for the specified active ingredients under Section 130a (8) of the Social Code Book V (SGB V) through an 'Open-House' procedure. This process allows all eligible and interested pharm
This contract opportunity involves the establishment of non-exclusive discount agreements for the drug Trastuzumab, classified under ATC code L01FD01, in the regions of Lower Saxony, Bremen, and Saxony-Anhalt. The focus is on parenteral preparations made from finished medicinal products for oncology
